Castle Biosciences Inc
CSTL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001447362
In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 21 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Castle Biosciences Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 180 | 2 | 152 | −26 |
| Shares | 25.9M | 78.6K | 26.5M | +744.7K (+2.9%) |
| Value | $516.3M | $1.57M | $541.8M | +$27.1M (+5.3%) |
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Castle Biosciences Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 78,938 | $1.61M | 0.04% |
| Bridgeway Capital Management, LLC | 40,750 | $832.1K | 0.02% |
| Empowered Funds, LLC | 40,750 | $832.1K | 0.01% |
| Jump Financial, LLC | 21,858 | $446.3K | 0.01% |
| Aquatic Capital Management LLC | 19,280 | $393.7K | 0.01% |
| Manufacturers Life Insurance Company, The | 10,316 | $210.7K | 0.00% |
| Mount Yale Investment Advisors, LLC | 8,362 | $170.8K | 0.01% |
| Global Retirement Partners, LLC | 1,163 | $23.7K | 0.00% |
| Raymond James Financial Inc | 662 | $13.5K | 0.00% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 428 | $9.00K | 0.00% |
| Versant Capital Management, Inc | 126 | $2.57K | 0.00% |
| IFP Advisors, Inc | 36 | $1.27K | 0.00% |
| Signaturefd, LLC | 45 | $919 | 0.00% |
| Allworth Financial LP | 5 | $103 | 0.00% |
| Stephens Consulting, LLC | 2 | $41 | 0.00% |
| Twin Peaks Wealth Advisors, LLC | 1 | $19 | 0.00% |
Sold out (42)
Institutions that held Castle Biosciences Inc at the end of Q1 2025 and filed for Q2 2025 without it.
Not filed for Q2 2025 yet (2)
Institutions that held Castle Biosciences Inc at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Orion Portfolio Solutions, LLC | 78,409 | $1.57M |
| Lindbrook Capital, LLC | 179 | $3.58K |